Estimation and application of the minimum clinically important difference in COPD

The Lancet Respiratory Medicine

Volumn 2, Issue 3, 2014, Pages 167-169

  Jones, Paul W ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY QUESTIONNAIRE; COPD ASSESSMENT TEST; CORRELATION ANALYSIS; DETERIORATION; DISABILITY; DISEASE SEVERITY; HUMAN; INFORMATION PROCESSING; MEASUREMENT ERROR; METHODOLOGY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SELF EVALUATION; ST. GEORGE RESPIRATORY QUESTIONNAIRE; SYSTEMATIC ERROR; TREATMENT RESPONSE;

FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES;

EID: 84895826501     PISSN: 22132600     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-2600(14)70038-4     Document Type: Note

References (7)

1. Kon SSC, Canavan JL, Jones SE, et al. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med 2014, published online Feb 4. http://dx.doi.org/10.1016/S2213-2600(14)70001-3.
2. Jones PW, Beeh KM, Chapman KR, Decramer M, Mahler DA, Wedzicha JA Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med 2014, 189:250-255.
3. Barley EA, Jones PW Analysis of the cues used by patients when making assessments of their asthma severity. Eur Respir J 2005, 25:671-676.
4. Jones PW St George's Respiratory Questionnaire: MCID. J COPD 2005, 2:75-79.
5. Kendall MG A course in mulitivariate analysis 1957, Griffin, London.
6. Jones PW, Brusselle G, Dal Negro RW, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J 2011, 38:29-35.
7. Jones P, Tabberer M, Chen W-H Creating scenarios of the impact of COPD and their relationship to COPD assessment test (CAT) scores. BMC Pulm Med 2011, 11:42.